Tzeng, Y. T., Chiang, A., & Li, C. (2026). Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Chicago-Zitierstil (17. Ausg.)Tzeng, Yen-Dun Tony, An-Jen Chiang, und Chia-Jung Li. Targeting GCN5-mediated ERK Lactylation: A Promising Drug Development Frontier in Cancer Therapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026.
MLA-Zitierstil (9. Ausg.)Tzeng, Yen-Dun Tony, et al. Targeting GCN5-mediated ERK Lactylation: A Promising Drug Development Frontier in Cancer Therapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.